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Abstract
Amoxicillin is a first-line antibiotic treatment for acute otitis media in children and one of the most commonly used antibiotics for human
bacterial infections. We investigated changes in salivary bacterial communities among children treated with amoxicillin for acute otitis media
(n = 18), using a culture-independent approach based on pyrosequencing of the V3 region of the bacterial 16S rRNA gene. The control
group consisted of children with acute otitis media who were not given antibiotics (n = 15). One species-level phylotype assigned to the
genus Streptococcus was identified across all (n = 99) saliva samples. Two additional species-level phylotypes from the genera Gemella and
Granulicatella were shared by all (n = 45) samples of control subjects. Amoxicillin treatment resulted in reduced species richness and
diversity, and a significant shift in the relative abundance of 35 taxa at different ranks from phylum to species-level phylotype. At the phylum
level, prevalence of TM7 and Actinobacteria decreased at the end of treatment, whereas Proteobacteria had a higher relative abundance
post-treatment. Multivariate analysis showed that samples from the same control subject taken over time intervals tended to cluster
together. Among antibiotic-treated subjects, samples taken before and at the end of amoxicillin treatment formed two relatively well-
separated clusters both of which greatly overlapped with samples taken about 3 weeks post-treatment. Our results point to a substantial
but incomplete recovery of the salivary bacterial community from the antibiotic about 3 weeks after the end of treatment.
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Introduction
Antibiotic therapy causes changes in the composition and
abundance of commensal microbes; however, the long-term
effects of these changes remain largely unknown. In children
with recurrent acute otitis media (AOM), repeated courses of
antibiotics may reduce populations of beneficial bacteria,
removing barriers to colonization and growth for potential
pathogens [1,2]. Amoxicillin, a first-line antibiotic treatment
for AOM, may promote the emergence of Staphylococcus
aureus in the nasopharynx when commensal microbes are
killed by the antibiotic [1]. Amoxicillin use during the first
month of life results in decreased counts of faecal bifidobac-
teria and Bacteroides fragilis-group species [3]. A single-course
of amoxicillin eradicates Helicobacter pylori from the stomach in
20–50% of cases [4].
High-throughput sequencing of metagenome fragments or
amplified 16S rRNA has been widely applied to assess the
composition and structure of bacterial communities colonizing
the human body [5–7]. However, few studies have focused on
the effect of antibiotics on the microbiota, and they have
included a relatively small number of healthy volunteers [8–10].
Here, we investigated the changes in salivary microbiota in
children treated with amoxicillin for AOM. Because of the
anatomical proximity of the oral cavity and nasopharynx, the
latter being considered as a reservoir of causative agents of
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AOM, there is a possibility that the salivary microbiota may be
altered by AOM. Therefore, in our study the control group
consisted of children with AOM who were not given
antibiotics.
Materials and Methods
Patient information and sampling
The study was conducted according to the current version of
the Declaration of Helsinki and approved by the Ethics
Committee of the Geneva University Hospital (09-006).
This was a prospective cohort study conducted from
August 2009 to July 2010 in the emergency department of a
tertiary-care paediatric centre. We included children aged
from 12 to 72 months with clinically diagnosed AOM whose
parents gave informed consent for their participation in the
study. Exclusion criteria were pharyngitis and a history of
antibiotic treatment in the past 6 months. The amoxicillin
group (Group A, n = 18) were patients whose care providers
prescribed amoxicillin treatment. The control group (Group
C, n = 15) was defined with the same clinical criteria except
that their care providers did not prescribe antibiotics. Children
in the control group received only non-steroidal anti-inflam-
matory medications for their AOM.
Saliva was sampled from both groups of patients on three
occasions: at the time of initial visit (time point 1), after
about 10 days (time point 2, corresponding to the end of
the treatment for children prescribed amoxicillin), and about
1 month after the initial visit (time point 3). Saliva was
collected by gently rolling a swab under the tongue and
between the gum and the cheek. The swabs (Rayon swab
tip, Copan 155C; Copan ltalia, Brescia, Italy) were placed
into the original tubes and stored at 20°C until DNA
extraction.
DNA extraction
Fifty microlitres of lysis buffer [Tris 20 mM (pH 8), EDTA
2 mM, 1% Tween-20, 400 mg/L proteinase K (Fermentas,
Vilnius, Lithuania)] were applied directly to the swab tip. The
swab was inserted back into its container and incubated for
2.5 h at 55°C. Then, the swab head was cut from the stick and
placed in the inner tube of the Swab Extraction Tube System
(Roche, Basel, Switzerland). Samples were centrifuged for 30 s
at 16 000 g. The eluate was incubated at 95°C for 10 min to
inactivate proteinase K and stored at 20°C.
PCR and sequencing
We amplified the V1–3 region of the bacterial 16S rRNA gene
corresponding to Escherichia coli 16S rDNA positions 28–514
(excluding primer sequences). The PCRs included 3 µL
of DNA extract, 25 pmol of each forward primer 5′-
gccttgccagcccgctcag-ac-GAGTTTGATCMTGGCTCAG and a
barcoded reverse primer 5′-gcctccctcgcgccatcag-NNNNN-
NNN-at-CCGCGRCTGCTGGCAC in 50 lL of Primestar
HS Premix (TaKaRa, Shiga, Japan). The structure of composite
PCR primers has been explained previously [11].
All PCRs were carried out in duplicate for 30 cycles using
the following parameters: 98°C for 10 s, 56°C for 15 s and
72°C for 1 min. Two replicate PCRs were then pooled,
column-purified by using the QIAquick PCR Purification Kit
(Qiagen, Hilden, Germany) and eluted in 25 lL water. One
hundred and fifty nanograms of each of the purified samples
was pooled and the amplicon library was sequenced on a
Genome Sequencer FLX system (Roche) from the Fusion
Primer A.
Sequence analysis
Sequence filtering and analysis of sequence data were
performed using the MOTHUR software package [12]. We
removed sequences using any of the following criteria: (i) they
were <290 or >600 nucleotides in length; (ii) contained
ambiguous bases; (iii) contained more than one mismatch in
the reverse primer sequence (excluding the adaptor A
sequence); (iv) contained runs of  10 identical nucleotides;
and (v) had a minimum quality score <35 over a 50-nucleotide
window. Sequences were aligned (align.seq) against the SILVA
reference alignment set [13] and truncated to include bases
corresponding to E. coli 16S rDNA positions 257–514.
Removal of noise and removal of potentially chimeric
sequences were performed using MOTHUR’s commands
pre.cluster [14] and chimera.slayer [15], respectively.
Sequences were assigned to representative 97% identity
phylotypes (operational taxonomic units, OTUs) using CD-
HIT [16]. Taxonomic assignments of phylotypes were made
using the RDP CLASSIFIER [17] with an 80% cut-off. A trimmed
dataset (212 852 reads) was deposited in MG-RAST [18]
under accession number 4496634.3.
Clustering of bacterial communities, ecological indices and
statistical analysis
Multiple SILVA-based alignment of representative OTUs was
imported into FASTTREE [19] to construct a tree that was then
used as input file for the FAST UNIFRAC web interface [20]. A
Bray–Curtis similarity matrix was generated using square-root-
transformed abundance of OTUs. Principal coordinate analysis
was applied on the UNIFRAC distance matrix of all pairwise
combinations of communities. Chi-square test, Student’s t test,
Mann–Whitney U test, Wilcoxon signed-rank test and permu-
tational multivariate analysis of variance (PERMANOVA) were used
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to assess statistical significance. The PRIMER-E package
(Primer-E Ltd., Plymouth, UK) was used to calculate species
richness and diversity.
Results
Subjects and pyrosequencing results
Saliva samples were taken on three occasions (1–3) from
children with AOM, treated (A) or not treated (C) with
amoxicillin. Patient characteristics are presented in Table 1
and in Supplementary material, Table S1.
A total of 212 852 filtered pyrosequencing reads were
analysed. Trimmed sequences corresponded to the 16S rDNA
hypervariable region V3 and a part of the conserved region
between V2 and V3 (positions 257–514 in the E. coli 16S rRNA
gene) and had an average length of 257 nucleotides. We
extracted this region from the SILVA Bacterial reference set
(14 956 16S rRNA gene sequences) [13] to assess the
accuracy of taxonomic assignments. The proportion of such
simulated 454 reads correctly and erroneously assigned at the
genus level, using RDP CLASSIFIER at a bootstrap cut-off of 80%,
reached 76% and 2%, respectively (see Supplementary mate-
rial, Fig. S1).
Taxon abundance
The six phyla (Firmicutes, Proteobacteria, Bacteroidetes,
Actinobacteria, TM7 and Fusobacteria), commonly found in
salivary bacterial communities [11,21–24], dominated the
samples in our study (Fig. 1 and Supplementary material, Table
S2). Averaging of the data from our study and published studies
[11,21–24] showed a trend of a higher proportion of
Firmicutes and a decrease in the frequency of six other major
phyla in saliva from children/adolescents in comparison to
adults (Fig. 1).
Two out of 81 genera identified, Amaricoccus and Moritella,
have not been previously found in the salivary microbiota
[11,21–24], but each of them had only one occurrence. This
supports the claim that the most frequent and widespread
members of the human salivary microbiome in the western
world have already been described [25]. However, the analysis
of samples from other geographic locations still identifies new
relatively abundant genera [26].
The dataset was represented by 11 028 distinct sequences
(100%-ID phylotypes) and 1 486 OTUs. In a recent study of
the salivary microbiome, which included 264 samples from 107
individuals aged from 8 to 24 years, two OTUs belonging to
the genus Streptococcus were found in all but one sample and
corresponded to 10.5% of all sequence reads [27]. Here, on a
cohort including 33 subjects aged 1–6 years, 18 of which were
exposed to the antibiotic, an OTU was identified across all
time-point samples of all individuals (99 samples). It was also
assigned to the genus Streptococcus and represented on
average 44.6% of the total number of sequence reads per
sample. Two additional OTUs from the genera Gemella and
Granulicatella were shared by all (n = 45) samples of control
subjects. After combining the sequence reads of the three
time-point samples from the same individual into a single
TABLE 1. Patients’ characteristics
Antibiotic group
(n = 15)
Control group
(n = 18) pa
Mean age (months  SD) 23  14 34  18 0.07
Male sex 11 (61%) 6 (40%) 0.23
Antibiotic treatment in
last 12 months
6 (33%) 3 (20%) 0.39
aChi-square test was used to compare proportions between groups.
A Student t test was used to compare continuous variables (mean age).
A level of p <0.05 was considered significant.
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FIG. 1. Relative abundance of seven major phyla across different
studies of the salivary microbiome. Data obtained for different
individuals (and different time-points if available) were averaged for
each study except that of Keijser et al. [24] in which individual non-bar-
coded amplicon libraries were pooled in equimolar amounts before
sequencing. ‘A’ and ‘C’ correspond to the treated and untreated group
of children analysed in this study, respectively. ‘Children/adolescents
AVG’ and ‘Adults AVG’ were obtained by averaging data from the
relevant studies.
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dataset, the ‘universal core’ of the entire cohort reached an
average size of 69% and included 11 OTUs belonging to the
genera Streptococcus (4), Granulicatella (2), Gemella (2), Veillo-
nella (1), Coprococcus (1) and Fusobacterium (1).
The assessment of differences in relative taxon abundance
at different visits (1, 2 and 3) revealed 39 significant changes
within the antibiotic-treated (A) group and none within the
control (C) group (Table 2). In all cases (31) where a
statistically significant shift in the average taxon abundance
was found between pre-treatment (A1) and end-of-treatment
(A2) samples, we also observed the opposite direction of
change between end-of-treatment and post-treatment (A3)
samples, which points to a recovery from antibiotic treatment.
The end of treatment correlated among others with a
reduced proportion of the phyla TM7 and Actinobacteria,
genera Corynebacterium, Rothia, Atopobium, Prevotella, Solobac-
terium and Fusobacterium, as well as OTUs assigned to most of
these genera but also to Streptococcus and Gemella. The
proportion of two OTUs, assigned respectively to Abiotrophia
and order Burkholderiales, increased at the end of treatment.
Given the antibiotic spectrum of amoxicillin [28], the reduc-
tion in Streptococcus, Corynebacterium and Prevotella was
expected. In contrast, genera Neisseria and Haemophilus (and
OTUs assigned to them) were not consistently reduced at the
end of treatment.
Among 31 taxa with statistically significant changes in the
relative abundance between A1 and A2 samples, 13 had the
same direction of change (increase or decrease) in all
relevant individuals. For each of the remaining 18 taxa, the
change in one direction prevailed over the other (Table 2).
This was also the case with all the taxa showing significant
changes in relative abundance in A1–A3 and A2–A3 sample
comparisons.
At the post-treatment sampling point, Proteobacteria were
significantly more abundant, whereas phylum TM7, class
Clostridia, order Coriobacteriales and genus Prevotella had
lower relative abundances compared with the baseline (A1)
levels. It has been previously reported using the culture
method that amoxicillin treatment reduced the number of
Prevotella spp. isolates considered to interfere with the growth
of potential pathogens in the nasopharynx [1].
Microbiota clustering
We compared the saliva bacterial communities in terms of
their phylogeny within the antibiotic-treated and control
groups using UNIFRAC. Principal coordinate analysis of un-
weighted UNIFRAC distances in group C showed that samples
taken from the same individual over time tend to cluster
together (Fig. 2). In group A, the samples taken before and at
the end of the amoxicillin treatment formed two relatively well
separated clusters both of which partly overlapped with the
cluster formed by the post-treatment samples (Fig. 2). The
effect of antibiotic is clearly seen in the first two principal
coordinates where 16 (of 18) end-of-treatment samples (A2)
were displaced towards the left relative to the corresponding
pre-treatment samples (A1) and all their post-treatment (A3)
counterparts returned right. Similarly, 16 A2 samples were
displaced downwards relative to A1 and 11 of them moved
upwards at post-treatment.
For 12 individuals the A1–A2 and A2–A3 vectors on
principal coordinate analysis had opposite directions. Of
these, in ten cases (#A4, 5, 6, 15, 20, 21, 23, 24, 27, 32) the
A2 points moved down and left relative to A1 (see
Supplementary material, Fig. S2), whereas in two cases
(#A7, A10) other patterns were observed. For the remaining
six individuals (#A11, 12, 13, 16, 18, 28), the A1–A2 and A2–
A3 vectors were not in opposite directions; the only five
individuals who had the A1–A3 UNIFRAC distance greater than
the A1–A2 one were found among these six subjects.
Separation of pre-treatment and end-of-treatment samples
was less clear using weighted UNIFRAC analysis (see Supple-
mentary material, Fig. S3), although two-thirds of both A2
and A3 samples were located outside the area formed by the
A1 samples.
Variations of salivary microbiota among time-points for the
same control subject were smaller than those between
different control subjects at the same time point (Fig. 3 and
see Supplementary material, Fig. S4). In the antibiotic-treated
group, however, the average within-individual variations were
not significantly different from between-individual variations
(Fig. 3). Clearly, this was a result of the perturbation of the
microbiota by the antibiotic.
The results of PERMANOVA of unweighted UNIFRAC distances
confirmed the marked effect of the antibiotic on the salivary
microbiota (see Supplementary material, Table S3). Samples
taken at the end of amoxicillin treatment (A2) were signif-
icantly different from the five other groups of samples defined
by the treatment and medical visit (A1, A3, C1 C2, C3). Similar
results were obtained with PERMANOVA of Bray–Curtis similar-
ities. This test was based on square-root transformed abun-
dance of OTUs and did not take into account the phylogenetic
distance as was the case using UNIFRAC.
It has been shown that the oral microbiota is more stable
compared with other human microbiota [6], but most
important changes occur in childhood [23,27]. Our study did
not include children younger than 1 year, a period when
dramatic microbiota changes occur [22]. The result of
PERMANOVA (see Supplementary material, Table S4) suggested
that, at the time of the first visit, the salivary microbiota were
not significantly different between: (i) children belonging to
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TABLE 2. Changes in taxa abundance at different visits.
Rank and taxon
Taxonomic information (phylum;
class; order; family; genus)
Relative abundance p
Number of subjects
with increased/
decreased abundancea
A1 A2 A3
A2 vs.
A1
A3 vs.
A1
A3 vs.
A2
A2 vs.
A1
A3 vs.
A1
A3 vs.
A2Avg Med Avg Med Avg Med
Phylum
Actinobacteria
4.32 1.48 0.96 0.26 2.85 1.31 0.0070 0.0478 3/15 8/10 14/4
Phylum
Proteobacteria
7.32 4.64 21.35 8.75 12.75 8.17 0.0317 11/7 13/5 8/10
Phylum TM7 1.53 0.51 0.02 0.00 0.99 0.06 0.0019 0.0317 0.0478 0/17 2/15 9/1
Class
Actinobacteria
Actinobacteria 4.32 1.48 0.96 0.26 2.85 1.31 0.0114 3/15 8/10 14/4
Class Clostridia Firmicutes 6.24 4.61 4.21 2.34 2.38 1.75 0.0142 7/11 2/16 8/10
Class Erysipelotrichi Firmicutes 1.33 0.14 0.04 0.00 0.17 0.00 0.0114 0/12 4/10 6/2
Order
Actinomycetales
Actinobacteria; Actinobacteria 3.99 1.25 0.96 0.26 2.78 1.31 0.0214 4/14 9/9 14/4
Order
Coriobacteriales
Actinobacteria; Actinobacteria 0.33 0.08 0.00 0.00 0.06 0.00 0.0146 0.0337 0/12 1/12 5/0
Order
Clostridiales
Firmicutes; Clostridia 6.24 4.61 4.21 2.34 2.38 1.75 0.0205 7/11 2/16 8/10
Order
Erysipelotrichales
Firmicutes; Erysipelotrichi 1.33 0.14 0.04 0.00 0.17 0.00 0.0146 0/12 4/10 6/2
Order
Burkholderiales
Proteobacteria; Betaproteobacteria 0.80 0.19 9.68 2.64 0.68 0.42 0.0146 13/5 9/8 5/12
Family
Corynebacteriaceae
Actinobacteria; Actinobacteria;
Actinomycetales
0.34 0.16 0.05 0.00 0.11 0.00 0.0140 2/11 5/9 7/5
Family
Micrococcaceae
Actinobacteria; Actinobacteria;
Actinomycetales
1.95 0.38 0.13 0.00 0.83 0.28 0.0133 2/13 8/9 14/1
Family
Coriobacteriaceae
Actinobacteria; Actinobacteria;
Coriobacteriales
0.33 0.08 0.00 0.00 0.06 0.00 0.0133 0/12 1/12 5/0
Family
Aerococcaceae
Firmicutes; Bacilli; Lactobacillales 0.24 0.12 1.70 0.31 0.21 0.12 0.0183 13/4 7/9 6/10
Family
Erysipelotrichaceae
Firmicutes; Erysipelotrichi;
Erysipelotrichales
1.33 0.14 0.04 0.00 0.17 0.00 0.0133 0/12 4/10 6/2
Family
Fusobacteriaceae
Fusobacteria; Fusobacteria;
Fusobacteriales
0.96 0.59 0.13 0.00 0.64 0.23 0.0003 1/17 6/12 10/6
Genus
Corynebacterium
Actinobacteria; Actinobacteria;
Actinomycetales; Corynebacteriaceae
0.34 0.16 0.05 0.00 0.11 0.00 0.0170 2/11 5/9 7/5
Genus Rothia Actinobacteria; Actinobacteria;
Actinomycetales; Micrococcaceae
1.95 0.38 0.12 0.00 0.83 0.28 0.0170 1/13 8/9 14/1
Genus Atopobium Actinobacteria; Actinobacteria;
Coriobacteriales; Coriobacteriaceae
0.33 0.07 0.00 0.00 0.06 0.00 0.0170 0/11 2/11 5/0
Genus Prevotella Bacteroidetes; Bacteroidia; Bacteroidales;
Prevotellaceae
0.92 0.54 0.58 0.32 0.25 0.15 0.0347 5/13 3/15 8/10
Genus Abiotrophia Firmicutes; Bacilli; Lactobacillales;
Aerococcaceae
0.24 0.12 1.70 0.31 0.21 0.12 0.0192 13/4 7/9 6/10
Genus
Solobacterium
Firmicutes; Erysipelotrichi;
Erysipelotrichales; Erysipelotrichaceae
1.31 0.14 0.04 0.00 0.17 0.00 0.0170 0/12 4/10 6/2
Genus
Fusobacterium
Fusobacteria; Fusobacteria;
Fusobacteriales; Fusobacteriaceae
0.96 0.59 0.13 0.00 0.64 0.23 0.0003 1/17 6/12 10/6
OTU1357 Actinobacteria; Actinobacteria;
Actinomycetales; Micrococcaceae;
Rothia
0.28 0.19 0.03 0.00 0.12 0.00 0.0241 0/13 5/10 7/1
OTU1364 Actinobacteria; Actinobacteria;
Actinomycetales; Micrococcaceae; Rothia
1.65 0.14 0.10 0.00 0.70 0.22 0.0378 1/11 9/7 13/1
OTU1354 Actinobacteria; Actinobacteria;
Coriobacteriales; Coriobacteriaceae;
Atopobium
0.32 0.07 0.00 0.00 0.06 0.00 0.0241 0/11 2/11 5/0
OTU502 Firmicutes; Bacilli; Bacillales;
Staphylococcaceae; Gemella
1.40 1.16 0.26 0.08 1.21 0.50 0.0241 2/16 5/13 14/3
OTU609 Firmicutes; Bacilli; Lactobacillales;
Aerococcaceae; Abiotrophia
0.22 0.10 1.54 0.25 0.17 0.11 0.0419 12/5 7/9 5/10
OTU382 Firmicutes; Bacilli; Lactobacillales;
Streptococcaceae; Streptococcus
4.44 3.50 1.77 0.08 1.85 0.49 0.0401 3/14 4/13 10/6
OTU1026 Firmicutes; Erysipelotrichi;
Erysipelotrichales; Erysipelotrichaceae;
Solobacterium
1.29 0.14 0.04 0.00 0.17 0.00 0.0241 0/12 4/10 6/2
OTU1408 Fusobacteria; Fusobacteria; Fusobacteriales;
Fusobacteriaceae; Fusobacterium
0.74 0.46 0.10 0.00 0.54 0.17 0.0011 1/17 8/10 10/6
OTU478 Proteobacteria; Betaproteobacteria;
Burkholderiales
0.77 0.19 9.44 2.34 0.64 0.33 0.0241 13/5 9/8 5/12
OTU1502 TM7 0.44 0.10 0.00 0.00 0.38 0.00 0.0241 0/11 3/10 5/1
OTU1577 TM7 0.88 0.31 0.01 0.00 0.51 0.00 0.0241 0/13 2/12 8/0
A, treated subjects; 1, 2 and 3 correspond to the first, second and third medical visit, respectively; Avg, average; Med, median.
Only taxa found at >0.25% in at least one of the six groups of samples (A1, A2, A3, C1, C2, C3) were analysed and those with significant changes (p <0.05) are presented. The
statistical analysis was a Wilcoxon signed-rank test with Benjamini–Hochberg correction for multiple comparisons (for each taxonomic level individually).
Only significant p values are presented.
aNumber of samples with increased abundance/Number of samples with decreased abundance.
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different age groups defined by 1-year increments (see
Supplementary material, Fig. S5), except when 1–2-year-old
children were compared with those who were 5–6 years old;
(ii) genders; and (iii) patients prescribed (A1) and not
prescribed (C1) amoxicillin. Previous AOM episodes,
recorded in 11 patients, nine of which were treated by
antibiotics, showed a weak effect on the salivary microbiota
when a PERMANOVA test based on unweighted UNIFRAC distances
was used (Pseudo-F = 1.5193, p 0.043).
Diversity of the salivary microbiota
Diversity and richness estimates are considered to be sensitive
to the number of sequences analysed [29], so we normalized
the data of each sample to 283 sequences, as it was the lowest
number of sequences in any sample. Margalef richness and
Shannon diversity indices were lower in 17 and 16 (of 18) A2
samples, respectively, in comparison to their A1 counterparts
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FIG. 4. Richness and diversity indices of the salivary bacterial
communities. Margalef richness (d) and Shannon diversity (H‘) indices
were calculated for the six groups of samples. Each sample was
normalized to 283 sequences before analysis. Average values and
standard error bars are presented. The statistical analysis was
Wilcoxon signed-rank test.
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(see Supplementary material, Table S5). The average values for
both indices in A3 samples were between values found in A1
and A2 samples (Fig. 4). In the control group, the average
diversity and richness indices were somewhat reduced in
samples taken at the time of the second visit in comparison to
the baseline and third-visit samples, but these differences were
not statistically significant. Decrease in Shannon diversity and
Margalef richness indices, observed in 13 and 11 (of 15)
control subjects, respectively, may be the result of some
changes in diet, hygiene or immunological status linked to the
illness.
Discussion
The present paper represents the only controlled study
showing the impact of antibiotic treatment on the human
salivary microbiome in the context of AOM. In spite of the
inter-individual differences in the salivary microbiota profiles at
baseline, common themes in microbiota perturbations caused
by the amoxicillin treatment were revealed.
Salivary bacterial communities were in great part recovered
3 weeks after the course of amoxicillin, but some effects of the
antibiotic treatment were still seen, e.g. lower species richness
and diversity.
At the phylum level amoxicillin effect was the strongest on
TM7 and Actinobacteria. The proportion of TM7, identified in
17 (of 18) individuals at pre-treatment, dropped below the
detection limit in 88% and 41% of these subjects at the end of
treatment and post-treatment, respectively. The biology of
TM7 bacteria, which so far have no culturable representatives,
their interaction with other members of the oral microbial
consortium, and their possible impact on oral (and general)
health are unknown. After averaging the data from several
salivary microbiomes [11,21–24], TM7 stands as the sixth most
abundant phylum in both adults and children/adolescents, with
a frequency higher than that of Spirochaetes (Fig. 1). Data
from our study show that, in some samples, the sequences
assigned to TM7 may represent up to 20% of the total number
of reads in the salivary 16S amplicon libraries.
Responses of the salivary microbiota to amoxicillin were
individualized as it has been previously shown for the gut
microbiota of ciprofloxacin-treated individuals [9]. These
variations may be a result of: (i) differences among individuals
in pharmacokinetics and pharmacodynamics of amoxicillin; (ii)
various duration of antibiotic therapy and time intervals
between visits at which the participants were sampled; (iii)
lifestyle differences between patients; (iv) some seasonal
phenomena during the 10-month study duration; and (v)
different patterns of subject colonization by antibiotic-resistant
strains. Indeed, a wide variety of amoxicillin-resistant bacteria
were commonly identified in the dental plaque of children [30].
Not only do antibiotics alter the microbiota membership
and composition, they also increase the prevalence of antibi-
otic resistance. Resistance to antibiotics prescribed in primary
care may persist for up to 4 years [31]. Number of courses of
an antibiotic, its doses and course duration may influence the
prevalence of antibiotic resistance and induce changes that may
influence the response to later antibiotic-driven perturbations
[9,32]. It would be of interest to include these aspects of the
microbiota changes in future studies of the salivary as well as
the nasopharyngeal bacterial communities, the latter being
considered as a reservoir of causative agents of AOM.
All the patients enrolled in our study had recovered at the
time of the second visit, regardless of the use of amoxicillin.
According to the current recommendations [33], amoxicillin
treatment was mostly limited to children with severe AOM.
Long-term effects of antibiotics on the oral (and other) human
microbiota may be regarded as an additional argument to
further reduce their prescription in AOM.
Acknowledgements
These results were presented, in part, at the Annual Congress
2012 of the Swiss Society for Microbiology, St Gallen,
Switzerland.
Transparency Declaration
The authors declare no conflicts of interest.
Supporting Information
Additional Supporting Information may be found in the online
version of this article:
Figure S1. Accuracy of taxonomic assignments for the V3
region of the SILVA Bacterial reference 16S rRNA gene
sequences.
Figure S2. Samples from ten treated individuals showing
similar trajectories in the first two ordination axes in the
principal coordinate analysis plot of unweighted UNIFRAC
distances.
Figure S3. Principal coordinate analysis of weighted
UNIFRAC distance matrices.
Figure S4. Intra-individual and inter-individual unweighted
UNIFRAC distances in the treated (a) and control (b) patient
group.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, E335–E342
CMI Lazarevic et al. The salivary microbiome in the disease E341
Figure S5. Principal coordinate analysis of unweighted
UNIFRAC distances between salivary microbial communities at
the first medical visit.
Table S1. Details of the patients’ characteristics and
treatment.
Table S2. Relative abundance of taxa in saliva samples.
Table S3. Pairwise comparisons between the group of
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